Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder

Summary

Depressed patients will receive 6 weeks of citaloprma (20-40mg) therapy. Subjects who have an inadequate response (partial or non-responder) will be randomized to receive either mecamylamine (5-10mg) or placebo added to their citalopram for a further 8 weeks.

Timeline

Start

2005-02

Primary completion

—

Completion

2006-08

Drugs

Indications